138 related articles for article (PubMed ID: 16999816)
21. Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
[TBL] [Abstract][Full Text] [Related]
22. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
23. The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma.
Utsunomiya H; Suzuki T; Ito K; Moriya T; Konno R; Sato S; Yaegashi N; Okamura K; Sasano H
Clin Endocrinol (Oxf); 2003 Jun; 58(6):696-703. PubMed ID: 12780745
[TBL] [Abstract][Full Text] [Related]
24. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
van der Putten LJM; Visser NCM; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Werner HMJ; Amant F; Massuger LFAG; Pijnenborg JMA
Int J Gynecol Cancer; 2018 Mar; 28(3):514-523. PubMed ID: 29324536
[TBL] [Abstract][Full Text] [Related]
25. Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.
Bonneterre J; Hutt E; Bosq J; Graham JD; Powell MA; Leblanc E; Fujiwara K; Herzog TJ; Coleman RL; Clarke CL; Gilles EM; Zukiwski AA; Monk BJ
Gynecol Oncol; 2015 Sep; 138(3):663-7. PubMed ID: 26142884
[TBL] [Abstract][Full Text] [Related]
26. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
[TBL] [Abstract][Full Text] [Related]
27. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma.
Balleine RL; Earls PJ; Webster LR; Mote PA; deFazio A; Harnett PR; Clarke CL
Int J Gynecol Pathol; 2004 Apr; 23(2):138-44. PubMed ID: 15084842
[TBL] [Abstract][Full Text] [Related]
28. Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies.
Akahira J; Inoue T; Suzuki T; Ito K; Konno R; Sato S; Moriya T; Okamura K; Yajima A; Sasano H
Br J Cancer; 2000 Dec; 83(11):1488-94. PubMed ID: 11076658
[TBL] [Abstract][Full Text] [Related]
29. Progesterone receptor isoform identification and subcellular localization in endometrial cancer.
Leslie KK; Stein MP; Kumar NS; Dai D; Stephens J; Wandinger-Ness A; Glueck DH
Gynecol Oncol; 2005 Jan; 96(1):32-41. PubMed ID: 15589577
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Shen XM; Li HG; Chen LH; Wang XY; Luo X; Lin ZQ; Jiang GY
Pathol Res Pract; 2012 Dec; 208(12):730-5. PubMed ID: 23122929
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
32. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
33. Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma.
Witek A; Paul-Samojedny M; Stojko R; Seifert B; Mazurek U
Gynecol Oncol; 2007 Aug; 106(2):407-12. PubMed ID: 17561234
[TBL] [Abstract][Full Text] [Related]
34. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma.
Miyamoto T; Watanabe J; Hata H; Jobo T; Kawaguchi M; Hattori M; Saito M; Kuramoto H
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):111-8. PubMed ID: 15555905
[TBL] [Abstract][Full Text] [Related]
35. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.
Sivridis E; Giatromanolaki A; Koukourakis M; Anastasiadis P
Virchows Arch; 2001 May; 438(5):470-7. PubMed ID: 11407475
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.
Köbel M; Atenafu EG; Rambau PF; Ferguson SE; Nelson GS; Ho TC; Panzarella T; McAlpine JN; Gilks CB; Clarke BA; Bernardini MQ
Gynecol Oncol; 2016 Jun; 141(3):559-563. PubMed ID: 27072807
[TBL] [Abstract][Full Text] [Related]
37. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
38. Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors.
Bartosch C; Monteiro-Reis S; Vieira R; Pereira A; Rodrigues M; Jerónimo C; Lopes JM
PLoS One; 2015; 10(8):e0134969. PubMed ID: 26252518
[TBL] [Abstract][Full Text] [Related]
39. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
Liao QP; Wu C; Zheng H; Yu L
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
[TBL] [Abstract][Full Text] [Related]
40. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]